cyclodepsipeptid
enniat
verticilidefamili
repres
divers
class
highli
interest
natur
product
respect
manifold
biolog
activ
howev
stepwis
solidphas
synthesi
accomplish
due
difficult
combin
nmethyl
amino
acid
hydroxycarboxyl
acid
report
first
stepwis
solidphas
synthesi
anthelmint
cyclooctadepsipeptid
base
fmocthpeth
protect
group
strategi
wangresin
standard
condit
synthesi
allow
unproblemat
adapt
autom
peptid
synthes
depsipeptid
defin
heterodet
peptid
least
one
ester
bond
depsipeptid
contain
usual
irregular
ester
group
depsipeptid
altern
ester
bond
less
common
exampl
fig
highli
symmetr
natur
product
compris
verticilid
bassianolid
valinomycin
enniatin
regular
cyclodepsipeptid
share
sever
characterist
structur
featur
among
occurr
r
hydroxycarboxyl
acid
nmethyl
amino
acid
natur
depsipeptid
particular
cyclodepsipeptid
increas
interest
pharmaceut
research
wide
rang
biolog
activ
fig
instanc
valinomycin
well
known
potassiumselect
ionophor
recent
report
potent
agent
sever
acut
respiratorysyndrom
coronaviru
sarscov
verticilid
cyclooctadepsipeptid
isol
verticilium
sp
show
strong
select
inhibit
activ
ryanodin
bind
insect
bassianolid
anoth
cyclooctadepsipeptid
enniatin
larg
famili
cyclohexadepsipeptid
display
divers
biolog
activ
includ
antibiot
antifung
insecticid
antiprolif
cell
migrat
inhibitori
activ
cyclooctadepsipeptid
metabolit
mycelia
sterilia
rosselinia
sp
origin
isol
leav
camellia
japonica
establish
resistancebreak
anthelmint
low
toxic
anim
fig
cyclodepsipeptid
act
select
ion
transport
cellular
membran
despit
high
potenti
cyclodepsipeptid
drug
discoveri
limit
screen
structureeact
data
report
probabl
due
difficult
access
compound
combin
amino
acid
bulki
hydroxycarboxyl
acid
repres
formid
challeng
solidphas
synthesi
hand
prerequisit
prepar
larger
compound
collect
need
biolog
screen
stepwis
assembl
compound
expect
particularli
difficult
nmethyl
amino
acid
involv
due
increas
steric
hindranc
coupl
need
time
consequ
dioxomorpholin
format
epimer
becom
predomin
sidereact
difficulti
result
stepwis
assemblag
nmethyl
amino
acid
impress
demonstr
sever
cyclosporin
synthes
although
advanc
reagent
bmtb
dfet
develop
appli
coupl
steric
hinder
nmethyl
amino
acid
highyield
ester
bond
assemblag
solid
support
remain
synthet
problem
besid
standard
reagent
dicdmap
alsotriphosgen
hexafluoroacetonid
ahydroxycarboxyl
acid
employ
construct
depsipeptid
abbrevi
acn
acetonitril
boc
tertbutyloxycarbonyl
bopcl
n
n
bi
phosphin
chlorid
dcm
dichloromethan
dead
diethylazodicarboxyl
dhp
dic
n
n
diisopropylcarbodiimid
diea
diisopropylethylamin
dmap
dmf
dimethylformamid
dmso
dimethylsulfoxid
edci
methiodid
fmoc
hatu
n
n
n
n
tetramethylo
uroniumhexafluorophosph
hoat
hobt
meoh
methanol
tea
triethylamin
tfa
trifluoro
acet
acid
thf
tetrahydrofuran
thp
tetrahydropyranyl
tpp
triphenylphosphan
ptsoh
paratoluenesulfon
acid
usual
ester
bond
either
assembl
beforehand
solut
peptid
bond
form
resin
hydroxycarboxyl
acid
introduc
without
protect
procedur
publish
stepwis
solidphas
depsipeptid
synthes
impress
one
compris
twentyfour
step
total
synthesi
cyclododecadepsipeptid
valinomycin
includ
onresin
format
six
ester
bond
howev
stepwis
solidphas
synthes
depsipeptid
contain
nmethyl
amino
acid
accomplish
paper
wish
report
solidphas
total
synthesi
cyclooctadepsipeptid
esterand
amidebond
form
support
principl
frequent
use
fmocand
bocprotect
group
strategi
applic
also
solidphas
synthesi
depsipeptid
howev
problem
ester
bond
involv
basic
condit
need
remov
fmocgroup
may
caus
partial
ester
cleavag
diketopiperazin
format
enhanc
racem
chiral
hydroxi
acid
hand
fmocprotect
scheme
well
establish
standard
support
wangresin
easili
adapt
peptid
synthes
diketopiperazin
format
drastic
reduc
even
suppress
strong
acid
cleavag
condit
use
cleavag
boc
protect
group
howev
activ
ester
bond
phlac
instanc
may
affect
addit
resin
compat
bocprotect
mainli
kaiseroxim
pamresin
significantli
expens
lower
load
compar
wangresin
silyl
ether
acetyl
group
employ
solidphas
synthes
protect
group
ohfunct
hydroxi
acid
acetyl
group
cleav
strong
basic
condit
bear
risk
racem
silyl
ether
appear
gener
unsuit
coupl
nmethyl
amino
acid
hydroxi
acid
due
steric
shield
bulki
silyl
residu
reason
chose
thpprotect
group
cleav
mild
acid
condit
compat
even
bocprotect
group
fmoc
protect
nmethyl
leucin
thp
protect
hydroxi
acid
prepar
accord
standard
literatur
procedur
scheme
first
use
kaiseroxim
resin
alreadi
appli
success
cours
didepsipeptid
segment
synthesi
emodepsid
howev
consider
longer
stepwis
synthesi
deletionand
failuresequ
accumul
accompani
prematur
cleavag
resin
result
insepar
mixtur
product
six
seven
coupl
second
attempt
chose
wangresin
well
awar
potenti
problem
aris
basic
cleavag
condit
fmocgroup
sinc
strongli
solvat
dmf
shown
unfavor
solvent
critic
coupl
respect
yield
diketopiperazin
format
degre
racem
use
less
solvat
thf
reagent
solubl
wangresin
still
show
good
swell
properti
coupl
step
small
portion
resin
cleav
product
analyz
hplcm
result
optim
experi
summar
tabl
expect
couplingyield
strongli
depend
residu
use
first
build
block
coupl
reagent
condit
thpphlac
use
anchoringresidu
due
lower
tendenc
form
dioxomorpholin
compar
thplac
could
coupl
resin
yield
reagent
mixtur
dicdmaphobt
entri
tabl
two
coupl
cycl
without
hobt
reactiv
reagent
system
distinctli
reduc
even
three
coupl
yield
remark
edci
fail
complet
even
hatu
use
quit
frequent
reagent
ester
format
gave
moder
coupl
yield
anchor
step
first
chainextens
reaction
ester
bond
anchor
phlac
fmocnmeleu
establish
best
yield
obtain
dic
dmaphobt
two
coupl
cycl
next
step
remov
fmocgroup
didepsipeptid
segment
particular
prone
format
dioxomorpholin
extens
studi
literatur
demonstr
critic
role
first
second
amino
acid
well
coupl
condit
steric
demand
amino
acid
val
leu
phe
first
posit
nmethyl
amino
acid
second
posit
exactli
compli
situat
gener
facilit
piperazinedion
format
even
care
optim
abl
reduc
dioxomorpholin
format
step
content
lower
cleavag
solut
noteworthi
follow
fmocgroup
remov
dixomorpholin
format
found
maximum
sever
method
test
coupl
thplac
resinbound
nmeleu
includ
thplac
acid
chlorid
entri
tabl
scheme
method
gave
low
yield
larg
due
insuffici
coupl
epimer
resincleavag
good
result
amid
bond
format
obtain
hatu
dicdmaphobt
reagent
sinc
carbodiimid
known
risk
racem
hatu
use
subsequ
amid
form
coupl
reaction
resinbound
lac
nmeleu
turn
difficult
previou
ester
format
wangresin
phlac
one
side
phlacnmeleu
side
scheme
thu
addit
dic
procedur
frequent
use
format
difficult
ester
bond
highli
reactiv
fmocnmeleu
acid
chlorid
yamaguchi
dichlorobenzo
activ
ester
entri
tabl
mitsunobo
entri
tabl
coupl
lactic
acid
studi
step
yamaguchi
method
afford
insuffici
yield
mitsunobo
reaction
gave
somewhat
higher
yield
howev
dicdmaphobt
reagent
system
remain
superior
also
coupl
step
standard
condit
use
remov
fmocprotect
group
thf
piperidin
min
thpprotect
group
remov
quantit
dilut
ptsoh
mgml
dcmmeoh
h
accord
procedur
publish
kuisl
due
symmetri
remain
four
chainelong
reaction
simpl
repeat
first
coupl
thu
optim
conduct
yield
linear
octadepsipeptid
remov
ntermin
fmocgroup
cleavag
resin
tfa
dcm
h
quantit
correspond
averag
yield
sixteen
step
solid
support
scheme
macrocycl
reaction
perform
highdilut
condit
dcm
bopcl
coupl
reagent
afford
almost
quantit
yield
regardless
whether
purifi
crude
precursor
employ
found
conveni
work
crude
octadepsipeptid
avoid
costli
timeconsum
prepar
hplc
purif
furthermor
easili
separ
noncycl
byproduct
flashchromatographi
silica
gel
due
consider
higher
lipophil
unusu
high
macrocycl
yield
attribut
cisamid
bond
leucin
lactic
acid
bring
nand
cterminu
close
proxim
thu
facilit
cyliz
reaction
obtain
synthesi
complet
ident
respect
biolog
spectroscop
data
natur
refer
sampl
develop
methodolog
stepwis
coupl
nmethyl
amino
acid
hydroxycarboxyl
acid
solid
support
allow
prepar
anthelmint
cyclooctadepsipeptid
overal
yield
rang
averag
yield
step
synthesi
compris
seventeen
step
sixteen
perform
solid
support
follow
solut
macrocycl
albeit
still
room
improv
particular
amidebond
form
step
standard
condit
allow
easi
adapt
autom
synthes
prerequisit
prepar
cyclodepsipeptid
screeninglibrari
start
materi
phenyllact
acid
either
purchas
prepar
standard
literatur
procedur
reaction
except
saponif
perform
dri
solvent
dichloromethan
reagent
diea
piperidin
reflux
h
calcium
hydrid
distil
thf
reflux
sever
hour
lialh
distil
toluen
dri
filtrat
basic
alumina
instrument
use
follow
h
nmr
c
nmr
spectra
record
c
gener
procedur
cleavag
resin
resin
mg
suspend
solut
ml
consist
tfa
dcm
agit
h
room
temperatur
resin
filter
wash
dcm
ml
combin
dcm
rins
wash
brine
dri
na
concentr
vacuo
usual
crude
product
immedi
use
macrocycl
reaction
without
purif
cyclooctadepsipeptid
bopcl
mg
mmol
ad
solut
crude
linear
octadepsipeptid
ppm
